On this page we presented the REGN Historical PE Ratio information for Regeneron Pharmaceuticals' stock. The average REGN historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 30.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average REGN historical PE based on this TTM earnings result method is 24.6.

Let's now compare this REGN historical PE result, against the recent PE: when this page was posted on 11/1/2024, the most recent closing price for REGN had been 843.60, and the most recent quarterly earnings result, annualized, was 49.84. Meanwhile, the most recent TTM earnings summed to 45.43. From these numbers, we calculate the recent REGN PE on 11/1/2024 based on annualized quarterly EPS was 16.9. Based on REGN's history, that recent PE is low relative to the historical average, with the recent PE 43.7% lower than the historical average PE across our data set for Regeneron Pharmaceuticals. Looking at the recent REGN PE on 11/1/2024 based on TTM EPS, we calculate the ratio at 18.6. Based on REGN's history, that recent PE is low relative to the historical average, with the recent PE 24.4% lower than the average PE across our Regeneron Pharmaceuticals data set with TTM EPS used in the calculation at each period.

Another interesting REGN historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for REGN, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for REGN, we start with the past four EPS numbers and we first sort them from lowest to highest: 9.55, 11.56, 11.86, and 12.46. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 11.56 and 11.86 — which gives us the median of 11.71. Basically the way to think about this 11.71 number is this: for the trailing four earnings reports, 11.71 marks the "middle ground" number where REGN has reported a value higher than 11.71 half the time, and has reported a value lower than 11.71 half the time. Annualizing that median value then gets us to 46.84/share, which we use as the denominator in our next PE calculation. With 843.60 as the numerator (as of 11/1/2024), the calculation is then 843.60 / 46.84 = 18.0 as the REGN PE ratio as of 11/1/2024, based on that annualized median value we calculated.

For self directed investors doing their due diligence on REGN or any other given stock, valuation analysis for REGN can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Regeneron Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for REGN. Thanks for visiting, and the next time you need to research REGN Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.